GlassScriptPhysician profile
Keith J Popovich
NPI 1467483412
$4,049.90
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,085 · 2020: $245 · 2021: $482 · 2022: $914 · 2023: $853 · 2024: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,249.28 | 2019-2024 | Tezspire, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $465.54 | 2019-2024 | Nucala, Trelegy Ellipta |
| Grifols USA, LLC | $304.41 | 2019-2023 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $160.77 | 2019-2024 | Yupelri |
| Alexion Pharmaceuticals, INC. | $125.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.58 | 2019-2023 | Stiolto Respimat, Ofev |
| Genzyme Corporation | $116.53 | 2021-2024 | |
| Actelion Pharmaceuticals US, INC. | $93.11 | 2022-2024 | Opsumit |
| Sunovion Pharmaceuticals INC. | $73.01 | 2019 | |
| Insmed, INC. | $71.60 | 2019-2023 | Arikayce |
| Bayer Healthcare Pharmaceuticals INC. | $50.23 | 2020-2023 | |
| Harmony Biosciences LLC | $46.03 | 2022 | |
| Electromed, INC. | $35.14 | 2022 | |
| Mallinckrodt Enterprises LLC | $25.56 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.06 | 2024 | Glassia |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $19.51 | 2019 | |
| United Therapeutics Corporation | $16.49 | 2019 | |
| Idorsia Pharmaceuticals US INC | $16.40 | 2022 | |
| Inspire Medical Systems, INC. | $14.93 | 2023 | Inspire |
| Shire North American Group INC | $14.65 | 2019 | |
| Advanced Respiratory, INC | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Popovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.